VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+15.66%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.45B
AUM Growth
+$1.45B
(+0.53%)
Cap. Flow
-$956K
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
77.82%
Holding
53
New
5
Increased
6
Reduced
5
Closed
5
Top Buys
| 1 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
$16.9M |
| 2 |
Verastem
VSTM
|
$11.4M |
| 3 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$9.55M |
| 4 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$9.41M |
| 5 |
Delcath Systems
DCTH
|
$6.87M |
Top Sells
| 1 |
Vaxcyte
PCVX
|
$21.7M |
| 2 |
Legend Biotech
LEGN
|
$11.8M |
| 3 |
Geron
GERN
|
$8.85M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$7.32M |
| 5 |
Merus
MRUS
|
$6.51M |
Sector Composition
| 1 | Healthcare | 99.19% |
| 2 | Materials | 0.55% |
| 3 | Consumer Staples | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVA
1
DELISTED
Sinovac Biotech, Ltd
SVA
| $615M | 42.47% | 5,900,000 | – | – |
|
2
Harmony Biosciences
HRMY
$2.12B
| $91.7M | 6.33% | 2,606,247 | – | – |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $89.8M | 6.2% | 4,249,918 | – | – |
|
|
AVDL
4
Avadel Pharmaceuticals
AVDL
$1.43B
| $63.1M | 4.36% | 3,829,577 +68,139 | +2% | +$1.12M |
|
5
Terns Pharmaceuticals
TERN
$609M
| $58.3M | 4.02% | 6,657,992 | – | – |
|
|
6
Geron
GERN
$893M
| $53M | 3.66% | 16,524,634 -2,758,200 | -14% | -$8.85M |
|
7
Tarsus Pharmaceuticals
TARS
$2.47B
| $40.9M | 2.82% | 2,262,200 | – | – |
|
8
Viridian Therapeutics
VRDN
$1.5B
| $39.9M | 2.76% | 1,678,207 | – | – |
|
|
VECT
9
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $39.4M | 2.72% | 2,333,300 | – | – |
|
|
KDNY
10
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $35.9M | 2.48% | 934,879 +62,728 | +7% | +$2.41M |
|
11
ALX Oncology
ALXO
$62.7M
| $31.7M | 2.19% | 4,220,048 | – | – |
|
12
Cogent Biosciences
COGT
$1.69B
| $26.6M | 1.83% | 2,244,941 +250,000 | +13% | +$2.96M |
|
|
ICVX
13
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $16.9M | 1.17% | +1,704,568 | New | +$16.9M |
|
|
GRCL
14
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $15.1M | 1.04% | 3,969,427 +2,505,444 | +171% | +$9.55M |
|
15
Astria Therapeutics
ATXS
$349M
| $14M | 0.97% | 1,681,199 | – | – |
|
16
Ventyx Biosciences
VTYX
$171M
| $13.8M | 0.96% | 422,075 -180,000 | -30% | -$5.9M |
|
17
Arcellx
ACLX
$3.85B
| $13.7M | 0.95% | 433,785 +143,072 | +49% | +$4.52M |
|
|
ALLK
18
DELISTED
Allakos
ALLK
| $13M | 0.9% | 2,988,000 -1,132,134 | -27% | -$4.94M |
|
19
Zai Lab
ZLAB
$3.68B
| $12.4M | 0.85% | 445,505 +28,865 | +7% | +$800K |
|
20
Olema Pharmaceuticals
OLMA
$375M
| $12.1M | 0.83% | 1,339,271 -350,244 | -21% | -$3.16M |
|
|
21
Verastem
VSTM
$569M
| $11.4M | 0.79% | +1,538,461 | New | +$11.4M |
|
22
Compass Therapeutics
CMPX
$483M
| $11.3M | 0.78% | 3,556,023 | – | – |
|
|
ASLN
23
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $10.4M | 0.72% | 2,840,908 -1 | -0% | -$4 |
|
|
ALPN
24
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $9.41M | 0.65% | +914,913 | New | +$9.41M |
|
25
Aclaris Therapeutics
ACRS
$209M
| $9.32M | 0.64% | 898,631 | – | – |
|